CareDx (CDNA) CFO Nathan Smith files initial report with no holdings

Rhea-AI Filing Summary

CareDx, Inc. filed an initial insider ownership report for its Chief Financial Officer, Nathan Smith. The filing states that he currently has no beneficial ownership of either non-derivative or derivative securities of CareDx. This means the CFO reports holding no company shares or related equity instruments in his name or through indirect arrangements.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SMITH NATHAN

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BLVD., 4TH FLOOR

(Street)

BRISBANE CA 94005

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/07/2025

3. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the latest insider filing for CDNA disclose about the CFO's holdings?

The filing reports that CareDx's Chief Financial Officer, Nathan Smith, has no securities beneficially owned, including both non-derivative and derivative securities.

What role does Nathan Smith hold at CareDx (CDNA) in this filing?

Nathan Smith is identified as an officer of CareDx, serving as Chief Financial Officer in the insider ownership report.

Does the CareDx (CDNA) CFO report owning any stock options or warrants?

No. The filing’s explanation of responses states that no securities are beneficially owned, which includes derivative securities such as options or warrants.

Is this CareDx (CDNA) insider ownership filing for more than one person?

No. The report is indicated as filed by one reporting person, covering only the holdings of Chief Financial Officer Nathan Smith.

What type of SEC form is this insider filing for CareDx (CDNA)?

This is a Form 3, which is an initial statement of beneficial ownership for insiders such as officers, directors, or large shareholders.